TLR4 and neoplasm: Clinical trials targeting metastatic soft tissue sarcomas have shown promising results with the intratumoral injection of the TLR4 agonist glycopyranosyl lipid A in a stable-emulsion formulation, combined with concurrent radiotherapy, achieving effective local control of the tumor.